Ignite Creation Date:
2025-12-24 @ 12:16 PM
Ignite Modification Date:
2025-12-27 @ 9:40 PM
Study NCT ID:
NCT02349061
Status:
COMPLETED
Last Update Posted:
2020-03-24
First Post:
2015-01-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-23
First Submit QC Date:
None
Study First Post Date:
2015-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-15
Results First Submit QC Date:
None
Results First Post Date:
2018-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-11
Last Update Post Date:
2020-03-24
Last Update Post Date Type:
ACTUAL